Advertisements For Anti Anxiety Medication

Ads for pharmaceutical drugs are everywhere. They are in magazines, on television and radio, on billboards, and on the little bags that you get from the pharmacist. These days it is difficult to get away from all the drug advertising. All these ads are for products that require a doctor's prescription. The goal of advertising is to increase profits. By advertising so heavily for drugs that the majority of the population does not need, pharmaceutical companies attempt to create as large a consumer base as they can. In advertising directly to the consumer, the drug companies accomplish two objectives. First, they get information directly to the consumer. Second, they promote the product and

Despite this, the industry did not alter its ways, maintaining that its ad campaigns were "educational," and that people were able to make their own decisions about what they purchased (Payer 66). However, it is evident that the advertisements produced by the pharmaceutical industry are designed for the very purpose of making it difficult for people to make these decisions independently. This marketing produces a large number of often deceptive, misleading tactics which have a large influence on both consumers and medical practitioners. The chief beneficiaries of this marketing are not the consumers but the pharmaceutical companies themselves.

There are proponents of DTC prescription drug ads. They argue that “the ads inform patients about diseases and possible treatments, encourage people to seek medical advice, help remove stigma associated with medical conditions, and provide needed sales revenue to fund costly research and development (R&D) of new drugs (Drug Ads ProCon.org).” On the flip side opponents argue “that DTC drug ads misinform patients, promote drugs before long-term safety-profiles can be known, medicalize and stigmatize normal conditions and bodily functions like wrinkles and low testosterone, waste valuable medical appointment time, and have led to our society’s overuse of prescription drugs (Drug Ads ProCon.org).”

In 2015, the pharmaceutical industry spent over 27 billion dollars on advertising. The two greatest components of this effort were promotional advertising and free medication sampling, which the pharmaceuticals invested 15.5 and 5.7 billion dollars respectively (“Persuading the Prescribers”). Promotional advertising involves direct contact with health professionals, the most common being extravagant lunch conferences held for physicians and their staff. On the other hand, sampling involves distributing free sample of medications to physicians, who then have a choice of providing these samples to patients. As a result of these methods, the industry has seen revenue around $400 billion with 90% of physicians having a relationship with a drug company (Campbell 2007). Moreover, the prices of prescriptions continue to rise; a copay of a generic drug is $11.72, preferred brand drug is $36.37 and a specialty drug is $58.37 (Coleman and Geneson 2014). Although the profits are immense in the numbers demonstrated above, it is no surprise when pharmaceutical drug companies elevate their prices even more. For instance, recently Turing Pharmaceuticals raised the price of their medication Daraprim from $13.50 to $750. Keep in mind, this medication is used for threatening parasitic infections, aids, and cancer with alternative options currently found to be inefficient (Pollack 2015). Another example of this practice involves cycloserine, a drug used to

Anyone who has stayed up late watching television, or has paged through a current magazine, has seen advertisements for medications. They often depict an individual, or couple, that is strolling along the beach, playing with their grandchildren, or enjoying a long forgotten hobby. Although the Food and Drug Administration has imposed stricter regulations on drug advertisements over the last several years, there remains an innate distraction and misleading by the drug companies in order to promote their product. “Evidence suggests that direct-to-consumer advertising of prescription drugs increases pharmaceutical sales and both helps to avert underuse of medicines and leads to potential overuse” (Donohue, Cevasco, & Rosenthal, 2007, p. 673). This paper will critique both a prescription and over-the-counter medication advertisement, discuss the pathophysiology and mechanism of action for the gastrointestinal disorder it treats, as well as compare and contrast the two advertisements.

Direct to consumer is a form of advertising that markets directly to consumers bypassing the distributor. In the mid 1980’s pharmaceutical

Annually, the US spends $300 billion dollars on pharmaceutical drugs. This is due to the over-diagnosing of certain conditions. Everyday, Americans are exposed to an enormous amount of advertisements for medications of all kinds. For example, 1 in 10 Americans are taking

We in America tend to take medications for almost any problem we have, from headaches to gastrointestinal pain, to more serious chronic disorders such as depression and attention deficit disorder. While many of the uses of such medications may be necessary and legitimate, many are not, and due to this fact, many people become dependent on medications, mentally, and or physically. This problem is not simply the fault of the individual; in fact, the blame can also be placed upon the medical community, and the pharmaceutical companies who produce the drugs. How often can one turn on the television to see advertisements for Claritin, Aspirin, Pepto-Bismol, or even Zoloft or Ritalin? The pharmaceutical industry is motivated by monetary

Most countries don't allow drug companies to advertise directly to patients. In the United States, however, direct-to-consumer (DTC) advertising of prescription drugs is completely legal. The article "Should prescription drugs be advertised directly to consumers?" questions the validity of this decision and provides several different examples of the advantages and disadvantages of DTC prescription drug ads. There are both positives and negatives associated with the advertising of prescription drugs.

The fact that the United States and New Zealand are the only two countries in the world that allow pharmaceutical companies to advertise directly to consumers is unreal to me. Through the Division of Drug Marketing, Advertising, and Communication (DDMAC), the FDA guarantee that all prescription drug promotion provides truthful, balanced, and accurate information (FDA, 2010); alongside with the risk the drug has to

In the January 18th 2016 issue of People Magazine, AstraZeneca ran an advertisement for Seroquel XR, an atypical antipsychotic. This advertisement was just one of seven prescription drug advertisements in the 94 page magazine, all urging readers to ask their doctors about a medication. These seven advertisements are a small sample of the direct-to-consumer (DTC) advertisement that flood television, radio, magazines, newspapers, and websites in the United States. The debate about whether DTC advertisement for psychotropic medication provides the consumer with more information and power over their medical care and reduces stigma or whether it leads to physicians to prescribing medications before assessing other treatment options and adds to the

Pharmaceutical companies and proponents of DTC advertising of prescription drugs argue that they create a more informed consumer, alerting them of possible ailments and new drugs.

There are many direct to consumer advertising for prescription drugs. On television, magazines, radio etc, you see the most recent advertisements for prescription drugs. After some people see the advertisements they soon rush over to their doctor and their illness and life would be perfectly pain and stress free. Making the public conscious of options for treatment is not a bad thing. But these false advertisements are misleading consumers onto unnecessary treatment.

Prescription drug advertisements have a negative impact on Americans by causing them to become hypochondriacs in a certain way. A hypochondriac is someone who believes and becomes obsessed with the idea that they have a serious condition that was and is undiagnosed. This problem continues to have a negative affect because it can lead to unnecessarily prescribing. Patients are going into their doctors and they are requesting to be put on these drugs because of the great affects that they have heard that they do for them. In the article, Direct-to-Consumer Pharmaceutical Advertising, the author states that in a study done over this and the results were that, when these request were made at about 40 percent of doctor visits and during this time more

One of the key manners in which direct-to-physician advertising of pharmaceuticals can lead to health promotion is in the reduction of malpractice on the part of physicians when it comes to the administering of pharmaceuticals. It is of course the primarily (and ultimately, solely) the physicians' responsibility to ensure the proper and effective use of pharmaceutical products, just as it is their responsibility to ensure that all care practices and interventions are in the best interests of the patient. Pharmaceutical companies have this goal and this responsibility as well, however, and they can be instrumental in making sure that true best interests are served with current knowledge of best practices and new potentials. As advertising is ultimately the provision of information, it can be seen that the direct advertising of pharmaceuticals to physicians can provide more comprehensive, detailed, and current information regarding new products, new uses, and the risks and benefits of specific pharmaceutical agents. The direct advertising constitutes an information-sharing relationship, and arming physicians with better information can only serve to assist them in their quest to achieve the best results for their patients (Schwartz et al, 2009).